NOTCH1 mutation predicts better clinical survival benefit of tislelizumab in second-line esophageal squamous cell carcinoma: a RATIONALE-302 study biomarker analysis
收藏数据链接：
官方服务：
资源简介：
In a mouse model of esophageal cancer, we conducted single-cell sequencing analysis of tumor tissues from mice with endogenous NOTCH1 knockout and control groups, finding that NOTCH1 mutation promotes a more immunoactive tumor microenvironment.
提供机构：
Jiao, Xi创建时间：
2024-08-19
